This document provides guidance on managing neonatal jaundice. It discusses how to suspect, measure, diagnose, approach, manage, and educate parents about physiological and pathological jaundice. Key points include that 60-80% of newborns develop jaundice, jaundice persisting beyond 14 days requires further investigation, and physiological jaundice is generally harmless and does not require treatment beyond observation.
Neonatal jaundice (hyperbilirubinemia) by Rajiv MavachiRajiv Mavachi
Jaundice is the most common condition that requires medical attention in newborns. The yellow coloration of the skin and sclera in newborns with jaundice is the result of accumulation of unconjugated bilirubin.
Neonatal jaundice (hyperbilirubinemia) by Rajiv MavachiRajiv Mavachi
Jaundice is the most common condition that requires medical attention in newborns. The yellow coloration of the skin and sclera in newborns with jaundice is the result of accumulation of unconjugated bilirubin.
This slide contains neonatal jaundice by including real case senario and nursing management through by passing definition, pathophysiology and diagnosis modality
This slide contains neonatal jaundice by including real case senario and nursing management through by passing definition, pathophysiology and diagnosis modality
My Powerpoint on Tuberculosis, includes:
What is the incidence and prevalence?
What are the symptoms?
How is it diagnosed?
How is it treated?
What are the treatment guidelines?
Neonatal jaundice occurs in 60% of term and 80% of preterm babies. Despite Neonatal jaundice is one of the commonest neonatal conditions, there are no national practice guidelines for its management in our country. Lack of uniform guidelines and standard practice parameters for diagnosis and management of neonatal jaundice often leads many babies to develop unnoticed hyperbilirubinemia causing kernicterus and long term poor neurological sequelae. This review after briefly discussing the epidemiology and pathophysiology of neonatal jaundice provides evidence-based pragmatic guidelines for the diagnosis and management of neonatal jaundice in resource-limited countries like Afghanistan
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
3. Introduction:
~60% of term and 80% of preterm babies
develop jaundice in the first wk of life.
10% of BF babies are still jaundiced at
1 month.
For most babies, jaundice is not an indication
of an underlying disease (termed 'physiological
jaundice') is generally harmless.
Prolonged jaundice –persisting beyond the
first 14 days in term babies and beyond 21
days in PT babies.
5. How to suspect:
Babies are more likely to develop significant
hyperbilirubinaemia if they have:
gestational age under 38 weeks.
a previous sibling with NJ requiring
phototherapy.
mother's intention to breastfeed exclusively
Visible jaundice in the first 24 hours.
6. How to measure: Kramer’s
Index
When looking for
jaundice (visual
inspection):
1-check the naked
baby in bright &
preferably natural light
2-examine the sclerae,
gums and blanched
skin is useful across all
skin tones.
1- Face 5 mg /dl
2-Upper trunk 10
3-Lower trunk & thighs 12
4-Arms &lower legs 15
5-Palms and soles
>15
7. How to measure: TC
Bilirubinometer
Use a TC bilirubinometer in
babies with GA of 35 weeks or
more and PN age of >24 hours
If a TC bilirubinometer is not
available, measure the serum
TB.
If a TC bilirubinometer
measurement > 250μmol/l (15
mg/dl) … check the result by
measuring the serum TB
8. How to diagnose: Causes
1. Appearing within 24 hours of age
-Hemolytic disease of newborn: Rh, ABO and minor group
incompatibility
-Infections: intrauterine viral, bacterial; malaria
-G-6PD deficiency
2. Appearing between 24-72 hours of life
-Physiological
-Sepsis neonatorum
-Polycythemia
-Concealed hemorrhages: cephalhematoma, subarachnoid bleed,
IVH.
-Increased enterohepatic circulation
3. Appearing after 72 hours
-Sepsis neonatorum
-Neonatal hepatitis
-Extra hepatic biliary atresia
10. Physiological Jaundice:
Immaturity in bilirubin metabolism at multiple
steps...
Characteristics:
· First appears between 24-72 hours of age
· Maximum intensity seen on 4-5th day in term and
7th day in preterm neonates
· Does not exceed 15 mg/ dl
· Clinically undetectable after 14 days.
· No treatment is required but baby should be
observed closely for signs of worsening jaundice.
11. Pathological Jaundice:
1-Clinical jaundice detected before 24 hours of age.
2-Rise in serum bilirubin by > 5 mg/dl/day.
3-Serum bilirubin >15 mg/dl.
4-Clinical jaundice persisting beyond 14 days of life.
5-Clay/white colored stool and/or dark urine staining
the clothes yellow.
6-Direct bilirubin >2 mg/ dl at any time.
*One should investigate to find the cause.
*Treatment is required in the form of phototherapy or
EPT.
12. How To Approach:
Check birth wt, GA ,PN age.
FH/o Jaundice or anemia or neonatal death..
Maternal and perinatal history…
Ask when jaundice was first noticed ?
Assess clinical condition…
Physiological or Pathological…
Look for clinical picture of kernicterus in
Newborns..
14. Refer for further investigation if:
Clinically unwell… poor feeding and lethargy …
Jaundice within 24 hours of life.
Jaundice below umbilicus, corresponding to serum bilirubin of
12-15 mg/dl (200-250 μmol/l ).
Jaundice up to level of the sole of the feet - likely to need
exchange transfusion.
Rapid rise of serum bilirubin of more than 8.5 μmol/l /hour
(>0.5 mg/dl/hour).
Prolonged jaundice of >14 days - other causes/conditions
need to be excluded e.g. neonatal hepatitis, biliary atresia.
Family history of significant haemolytic disease or kernicterus
Clinical symptoms/signs suggestive of other diseases e.g.
sepsis.
Direct bilirubin >20 %
15. Reduce level of bilirubin and prevent its toxicity by:
1-Early feeds and adequate hydration.
2-Reduction of Bilirubin by (Threshold table):
1-Phototherapy 2-IVIG 3-EBT.
How to manage in
general :
16. What to tell parents:
Offer parents or carers information about NJ that is tailored to their needs
and expressed concerns. Care should be taken to avoid causing
unnecessary anxiety to parents or carers. Information should include:
1-Factors that influence the development of significant hyperbilirubinaemia
2-How to check the baby for jaundice
3-What to do if they suspect jaundice
4-The importance of recognising jaundice in the first 24 hours and of seeking
urgent medical advice
5-The importance of checking the baby's nappies for dark urine or pale chalky
stools
6-The fact that NJ is common, &reassurance that it is usually transient and
harmless
7-Reassurance that breastfeeding can usually continue.
8-Provide lactation/feeding support to breastfeeding mothers whose baby is
visibly jaundiced.
17. To vaccinate or not:
Physiological Jaundice IS NOT a
contraindication.
Editor's Notes
In clinical practice, differentiating between physiologic jaundice from breast milk jaundice is important so that the duration of hyperbilirubinemia can be predicted. Identifying the infants who become dehydrated secondary to inadequate breastfeeding is also important. These babies need to be identified early and given breastfeeding support and formula supplementation as necessary. Depending on serum bilirubin concentration, Medical CareTreatment recommendations in this section apply only to healthy term infants with no signs of pathologic jaundice and are based on the severity of hyperbilirubinemia. In preterm, anemic, or ill infants and those with early (< 24 h) or severe jaundice (>25 mg/dL or 430 µmol/L), different treatment protocols should be pursued (see Jaundice, Neonatal).For healthy term infants with breast milk or breastfeeding jaundice and with bilirubin levels of 12 mg/dL (170 µmol/L) to 17 mg/dL, the following options are acceptable:Increase breastfeeding to 8-12 times per day and recheck the serum bilirubin level in 12-24 hours. The mother should be reassured about the relatively benign nature of breast milk jaundice (BMJ). This recommendation assumes that effective breastfeeding is occurring, including milk production, effective latching, and effective sucking with resultant letdown of milk. Breastfeeding can also be supported with manual or electric pumps and the pumped milk given as a supplement to the baby.Continue breastfeeding and supplement with formula.Temporary interruption of breastfeeding is rarely needed and is not recommended unless serum bilirubin levels reach 20 mg/dL (340 µmol/L). For infants with serum bilirubin levels from 17-25 mg/dL (294-430 µmol/L), add phototherapy to any of the previously stated treatment options. The reader is referred to the American Academy of Pediatrics' practice parameter on the management of hyperbilirubinemia in healthy full-term newborn infants.[10]The most rapid way to reduce the bilirubin level is to interrupt breastfeeding for 24 hours, feed with formula, and use phototherapy; however, in most infants, interrupting breastfeeding is not necessary or advisable.Phototherapy can be administered with standard phototherapy units and fiberoptic blankets. See the image below.
GP notebook :Inactivated or killed vaccines are generally safe and the only absolute contraindication is a severe local or general reaction to a previous dose.Live vaccines are contraindicated in pregnancy and in those who are on systemic steroid therapy or immunosuppressed for any reason. Vaccination may however be performed if the risks of infection exceed the risks of vaccination.Live vaccines should either be given simultaneously (if possible at different sites) or after a 3 week gap. (Except when BCG is given to infants when oral polio need not be delayed).12 weeks should elapse after a dose of human immunoglobulin before a live vaccine is administeredavoid during acute febrile illnessesBCG should not be given to eczema patients though otherwise eczema, hayfever, asthma and topical steroids are not contraindications to immunization.Premature infants, and those suffering from heart and lung diseases should be immunised according to the usual schedules. Premature infants should be immunized at the times recommended for full term babies, without correction for gestational ageThe following are not contraindications to vaccination, but folklore has had it in the past that they were:previous history of infectionstable neurological conditionantibiotic therapyallergic history, such as allergy to egg proteinsbreast feedingsibling of immune suppressed patient, except for live polio vaccine where a killed vaccine should be usedweightneonatal jaundice